ストックスクリーナーアプリを入手
2.49
3.49%
-0.09
アフターアワーズ：
2.52
0.03
+1.20%
前日終値:
$2.58
開ける：
$2.64
24時間の取引高:
3.49M
Relative Volume:
1.13
時価総額：
$277.98M
収益：
$1.88B
当期純損益:
$-534.51M
株価収益率:
-0.4837
EPS:
-5.1483
ネットキャッシュフロー:
$4.76M
1週間 パフォーマンス:
-17.55%
1か月 パフォーマンス:
-10.11%
6か月 パフォーマンス:
-70.32%
1年 パフォーマンス:
-74.01%
1日の値動き範囲:
$2.445
$2.68
1週間の範囲:
$2.445
$3.12
52週間の値動き範囲:
$2.445
$12.06
Evolent Health Inc Stock (EVH) Company Profile
名前
Evolent Health Inc
セクター
電話
571-389-6000
住所
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, TEM, BTSG, HQY, MMED
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
2.49 | 288.03M | 1.88B | -534.51M | 4.76M | -5.1483 |
VEEV
Veeva Systems Inc
|
185.23 | 30.26B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
49.14 | 8.40B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
42.10 | 7.92B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
81.64 | 6.84B | 1.31B | 215.20M | 408.32M | 2.4627 |
MMED
Minimed Group Inc
|
17.10 | 4.65B | 0 | 0 | 0 | 0.00 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-25 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-13 | 開始されました | BMO Capital Markets | Outperform |
| 2025-11-13 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2025-01-10 | 開始されました | Needham | Buy |
| 2024-12-03 | 繰り返されました | BTIG Research | Buy |
| 2024-11-08 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | アップグレード | Truist | Hold → Buy |
| 2024-04-22 | 開始されました | Citigroup | Buy |
| 2024-03-01 | 開始されました | Oppenheimer | Outperform |
| 2024-01-03 | 開始されました | Barclays | Overweight |
| 2023-12-06 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-10-16 | 開始されました | UBS | Buy |
| 2023-04-12 | 開始されました | Stephens | Overweight |
| 2022-11-01 | 開始されました | Truist | Hold |
| 2022-07-29 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-03-30 | 開始されました | Guggenheim | Buy |
| 2021-11-18 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-04-29 | 再開されました | JP Morgan | Neutral |
| 2021-01-07 | 開始されました | BTIG Research | Buy |
| 2020-07-06 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | ダウングレード | Goldman | Buy → Neutral |
| 2020-06-02 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | 再開されました | Leerink Partners | Outperform |
| 2018-06-04 | 開始されました | Piper Jaffray | Overweight |
| 2018-04-24 | 再開されました | JP Morgan | Neutral |
| 2017-09-20 | 開始されました | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | 開始されました | Robert W. Baird | Outperform |
| 2017-03-14 | 開始されました | Oppenheimer | Outperform |
| 2017-01-13 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | 再開されました | JP Morgan | Overweight |
| 2016-08-05 | 繰り返されました | FBR Capital | Outperform |
| 2016-07-26 | 開始されました | Jefferies | Buy |
| 2016-07-13 | 繰り返されました | FBR Capital | Outperform |
| 2016-03-29 | 開始されました | FBR Capital | Outperform |
| 2016-01-06 | 開始されました | Canaccord Genuity | Buy |
| 2015-06-30 | 開始されました | Goldman | Buy |
| 2015-06-30 | 開始されました | JP Morgan | Overweight |
| 2015-06-30 | 開始されました | Leerink Partners | Outperform |
| 2015-06-30 | 開始されました | Sun Trust Rbsn Humphrey | Buy |
すべてを表示
Evolent Health Inc (EVH) 最新ニュース
Aug Setups: How sensitive is Evolent Health Inc to inflation2026 EndofMonth & Growth Focused Entry Point Reports - baoquankhu1.vn
Will Evolent Health Inc benefit from geopolitical trendsEarnings Risk Report & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Aug Macro: How does Evolent Health Inc score in quality rankings2026 Decliners & Expert Verified Movement Alerts - baoquankhu1.vn
Evolent Health, Inc (NYSE:EVH) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Small-Cap Stock Risks: Declining Demand at Luxfer & Financial Strain at Evolent HealthNews and Statistics - IndexBox
Evolent Health Appoints New Chief Product Officer - Intellectia AI
Evolent announces appointment of Archie Mayani as chief product officer - itemonline.com
Doctor behind Cityblock joins Foodsmart to expand food as medicine for Medicaid - Stock Titan
Evolent Health at Oppenheimer Conference: Strategic Growth and Financial Focus - Investing.com Canada
EVH: Strong pipeline, conservative guidance, and focus on profitability drive growth outlook - TradingView
Fund Flows: What is the next catalyst for Evolent Health Inc2026 Review & Pattern Based Trade Signal System - baoquankhu1.vn
Forecast Cut: Is Evolent Health Inc currently under institutional pressure2026 Technicals & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Eventide Asset Management LLC Purchases 2,205,659 Shares of Evolent Health, Inc $EVH - MarketBeat
8 Knots Management LLC Lowers Position in Evolent Health, Inc $EVH - MarketBeat
Investor Alert: Unprofitable Companies with High Financial Risk in 2026News and Statistics - IndexBox
Evolent Health downgraded at KeyBanc on EBITDA recovery concerns - MSN
Evolent Health (NYSE:EVH) Shares Cross Below 50-Day Moving AverageHere's What Happened - MarketBeat
Aug Analyst Calls: What is Evolent Health Incs 5 year growth outlookQuarterly Portfolio Review & Weekly Watchlist of Top Performers - baoquankhu1.vn
Evolent Health, American Oncology Network Partner to Streamline Cancer Care - MSN
Gainers Report: How sensitive is Evolent Health Inc to inflationMarket Activity Summary & AI Forecasted Entry/Exit Points - baoquankhu1.vn
How Evolent Health Inc Class stock expands through international markets2026 Macro Impact & Verified Trade Idea Suggestions - Naître et grandir
Precision Trading with Evolent Health Inc Class A (EVH) Risk Zones - Stock Traders Daily
How The Evolent Health (EVH) Investment Story Is Shifting After Reserves Reset And Higher Leverage - Yahoo Finance
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know - Yahoo Finance
Profit Recap: Is Madison Square Garden Entertainment Corp stock influenced by commodity pricesWeekly Trend Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Evolent Health (NYSE: EVH) CEO reports PSU grant and tax-withheld share dispositions - Stock Titan
Evolent Health (EVH) president awarded PSUs and withholds shares for taxes - Stock Titan
Evolent Health (EVH) CAO awarded PSUs while shares withheld for taxes - Stock Titan
Evolent Health (EVH) CFO awarded 429,041 performance share units tied to 2027–2029 stock goals - Stock Titan
Evolent Health (NYSE: EVH) GC logs PSU grant and tax-share withholdings - Stock Titan
EVH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Cowen Maintains Buy on Evolent Health (EVH) March 2026, PT Cut to $7 - Meyka
TD Cowen cuts Evolent Health stock price target to $7 on 2026 outlook - Investing.com Canada
Oppenheimer Cuts Evolent Health (NYSE:EVH) Price Target to $6.00 - MarketBeat
Evolent Health (EVH) Receives Updated Analyst Rating from Oppenh - GuruFocus
Oppenheimer Adjusts Evolent Health Price Target to $6 From $12, Maintains Outperform Rating - marketscreener.com
Evolent Health Charts Growth Amid 2026 Margin Squeeze - TipRanks
Privia Health Expands Value Based Care Scale With Evolent ACO Acquisition - Yahoo Finance
Wall Street Zen Upgrades Evolent Health Stock Rating - National Today
Evolent Health (NYSE:EVH) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Evolent Health and iRhythm Shares Are Falling, What You Need To Know - Yahoo Finance
EVH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Is Evolent Health Inc affected by consumer sentimentTrade Risk Assessment & Risk Managed Investment Signals - baoquankhu1.vn
Evolent to Participate in Upcoming Investor Conferences - The Malaysian Reserve
Evolent Health price target lowered to $4 by Citigroup - National Today
EVH: Citigroup Maintains Buy Rating, Lowers Price Target | EVH S - GuruFocus
Evolent Health (NYSE:EVH) Price Target Lowered to $4.00 at Citigroup - MarketBeat
UBS Maintains Evolent Health (EVH) Rating, Lowers Price Target | - GuruFocus
UBS Group Lowers Evolent Health (NYSE:EVH) Price Target to $5.00 - MarketBeat
Privia Health Group, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Evolent Health: Cheap, Levered, But Ready To Rebound (NYSE:EVH) - Seeking Alpha
Evolent Health Inc (EVH) 財務データ
収益
当期純利益
現金流量
EPS
4.08%
0.87%
大文字化:
|
ボリューム (24 時間):